Device Trial Radar · NCT05364606
Patient Specific Talus Spacer Post Approval Study
Last checked: Nov 20, 2026Latest source record: Sep 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
50
Planned (sponsor's estimate)
Start
Jul 8, 2022
Primary completion
Aug 30, 2033
Study completion Nov 30, 2033
Sponsor
- Lead sponsor
- Paragon 28Not on our public-company list
- Sponsor type
- Industry
- First posted
- May 6, 2022
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 21 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Humanitarian Device Exemption Approved Patient Specific Talus Spacer Post Approval Study.
Conditions
- Avascular Necrosis of the Talus
Interventions
Patient Specific Talus SpacerDevice
Patient Specific Talus Spacer is a solid polished replica of the patient's bone.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Clinically Significant Improvement in Pain on the Visual Analog Scale (VAS)Time frame: At 5 years compared to Baseline
1 more outcomes with a free account
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Sutter Health Santa Rosa
Santa Rosa, California · Recruiting
4 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.